(Q47648317)

4 February 2018

title

Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA. (English)

1 reference

4 February 2018

1 reference

1 reference

H Sarikaya

1

1 reference

4 February 2018

M Yilmaz

2

1 reference

4 February 2018

N Michael

3

1 reference

4 February 2018

A R Miserez

4

1 reference

4 February 2018

B Steinmann

5

1 reference

4 February 2018

R W Baumgartner

6

1 reference

4 February 2018

publication date

11 June 2012

1 reference

4 February 2018

European Journal of Neurology

published in

1 reference

4 February 2018

volume

19

1 reference

4 February 2018

issue

11

1 reference

4 February 2018

page(s)

1421-1426

1 reference

4 February 2018

Clinical features of and recent advances in therapy for Fabry disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Aetiological diagnosis of ischaemic stroke in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Ischemic lacunar stroke in patients with and without potential mechanism other than small-artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Screening for Fabry disease in high-risk populations: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study--screening genetic conditions in Portuguese young stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

When should cardiologists suspect Anderson-Fabry disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

CNS manifestations of Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

Protocol and methodology of the Stroke in Young Fabry Patients (sifap1) study: a prospective multicenter European study of 5,024 young stroke patients aged 18-55 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03737.X

10.1111/J.1468-1331.2012.03737.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

22680335

1 reference

4 February 2018